Literature DB >> 27262516

Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors.

Bijo Mathew1, Abitha Haridas2, Gülberk Uçar3, Ipek Baysal4, Adebayo A Adeniyi5, Mahmoud E S Soliman5, Monu Joy6, Githa Elizabeth Mathew7, Baskar Lakshmanan2, Venkatesan Jayaprakash8.   

Abstract

Chalcone has been reported to be a valid scaffold for the design of monoamine oxidase (MAO) inhibitors. This scenario has amplified the momentum for the discovery of heteroaryl based chalcone MAO inhibitors. In the present study, we have synthesized a series of eleven chlorinated thienyl chalcone derivatives substituted with a different functional groups at the para- position on the ring B and investigated for their ability to inhibit human MAO-A and -B. With the exception of compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-nitrophenyl)prop-2-en-1-one (TC7), which was a selective MAO-A inhibitor, all the other derivatives inhibited hMAO-B potently and selectively with competitive mode of inhibition. The most potent compound (2E)-1-(4-chlorocyclopenta-1,3-dien-1-yl)-3-(4-ethylphenyl)prop-2-en-1-one (TC6) was found to be the best activity and higher selectivity towards hMAO-B with Ki and SI values of 0.31±0.02μM and 16.84, respectively. All the compounds presented in the current study are completely non-toxic with 74-88% viable cells to hepatic cells at 100μM concentration. Molecular docking and molecular dynamics simulation studies were carried out using Autodock-4.2 and Amber 14 to understand the molecular level interaction and energy relation of MAO isoforms with selective MAO-B inhibitor TC6.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Human monoamine oxidase; Molecular docking; Molecular dynamics; Thienyl chalcones

Mesh:

Substances:

Year:  2016        PMID: 27262516     DOI: 10.1016/j.ijbiomac.2016.05.110

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors.

Authors:  Bijo Mathew; Seung Cheol Baek; Della Grace Thomas Parambi; Jae Pil Lee; Monu Joy; P R Annie Rilda; Rugma V Randev; P Nithyamol; Vijitha Vijayan; Sini T Inasu; Githa Elizabeth Mathew; Krishnakumar K Lohidakshan; Girish Kumar Krishnan; Hoon Kim
Journal:  Medchemcomm       Date:  2018-09-25       Impact factor: 3.597

2.  Synthesis and Biological Evaluation of New Thiosemicarbazone Derivative Schiff Bases as Monoamine Oxidase Inhibitory Agents.

Authors:  Betül Kaya Çavuşoğlu; Begüm Nurpelin Sağlık; Derya Osmaniye; Serkan Levent; Ulviye Acar Çevik; Abdullah Burak Karaduman; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2017-12-28       Impact factor: 4.411

3.  Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors.

Authors:  Jong Min Oh; T M Rangarajan; Reeta Chaudhary; Rishi Pal Singh; Manjula Singh; Raj Pal Singh; Anna Rita Tondo; Nicola Gambacorta; Orazio Nicolotti; Bijo Mathew; Hoon Kim
Journal:  Molecules       Date:  2020-05-18       Impact factor: 4.411

4.  Hybrid Quinoline-Thiosemicarbazone Therapeutics as a New Treatment Opportunity for Alzheimer's Disease‒Synthesis, In Vitro Cholinesterase Inhibitory Potential and Computational Modeling Analysis.

Authors:  Sumera Zaib; Rubina Munir; Muhammad Tayyab Younas; Naghmana Kausar; Aliya Ibrar; Sehar Aqsa; Noorma Shahid; Tahira Tasneem Asif; Hashem O Alsaab; Imtiaz Khan
Journal:  Molecules       Date:  2021-10-30       Impact factor: 4.411

Review 5.  A Review of the Recent Developments of Molecular Hybrids Targeting Tubulin Polymerization.

Authors:  Oluwakemi Ebenezer; Michael Shapi; Jack A Tuszynski
Journal:  Int J Mol Sci       Date:  2022-04-04       Impact factor: 5.923

6.  Exploring the Therapeutic Potentials of Highly Selective Oxygenated Chalcone Based MAO-B Inhibitors in a Haloperidol-Induced Murine Model of Parkinson's Disease.

Authors:  Della Grace Thomas Parambi; Uzma Saleem; Muhammad Ajmal Shah; Fareeha Anwar; Bashir Ahmad; Amna Manzar; Aqsa Itzaz; Seetha Harilal; Md Sahab Uddin; Hoon Kim; Bijo Mathew
Journal:  Neurochem Res       Date:  2020-09-16       Impact factor: 3.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.